Litcius/Paper detail

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase

Cindy Meyer, Aitor Garzia, Michael W. Miller, David J. Huggins, Robert W. Myers, Hans-Heinrich Hoffmann, Alison W. Ashbrook, Syeda Y Jannath, Nigel J. Liverton, Stacia Kargman, Matthew Zimmerman, Andrew M. Nelson, Vijeta Sharma, Enriko Dolgov, Julianna Cangialosi, Suyapa Penalva-Lopez, Nadine Álvarez, Ching‐Wen Chang, Neelam Oswal, Irene González-Jiménez, Risha Rasheed, Kira Goldgirsh, Jada A. Davis, Lavoisier Ramos‐Espiritu, Miriam-Rose Menezes, Chloe S. Larson, Julius Nitsche, Oleg Ganichkin, Hanan Alwaseem, Henrik Molina, Stefan Steinbacher, J. Fraser Glickman, David S. Perlin, Charles M. Rice, Peter T. Meinke, Thomas Tuschl

2024Nature41 citationsDOI

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Coronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirusVirologyMethyltransferaseSars virusRNABiologyChemistryDiseaseMedicineGeneticsGeneInfectious disease (medical specialty)Internal medicineMethylationOutbreakRNA modifications and cancerMicroRNA in disease regulationRNA and protein synthesis mechanisms
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase | Litcius